MiMARK Diagnostics S.L

Startup
  • Location

    Hall 8.0 – 4YFN & Partner District Stand 8.0B10

Information

MiMARK is transforming diagnosis through gynecological fluids. Our proprietary GyLDa™ platform unlocks the clinical value of uterine and cervical fluids to deliver accurate, minimally invasive, and objective IVD solutions. MiMARK’s lead product, GyLD‑EC, is the first diagnostic developed within the GyLDa™ platform. GyLD‑EC is an in‑vitro diagnostic test designed to aid in the diagnosis of endometrial cancer (EC) using uterine fluid, with a targeted sensitivity of 97% and specificity of 78%.

Key Information

  • Growth Stage
    Seed
  • Country
    Spain
  • Founding Year
    2021